{"id":"iron-sucrose-venofer","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Hypotension"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"2-5%","effect":"Vomiting"},{"rate":"2-5%","effect":"Abdominal pain"},{"rate":"2-5%","effect":"Diarrhea"},{"rate":"1-5%","effect":"Injection site reactions"},{"rate":"<1%","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL1200823","moleculeType":"Small molecule","molecularWeight":"398.14"},"_dailymed":{"setId":"c59cb54c-bee5-96d6-e053-2995a90a767c","title":"VENOFER (IRON SUCROSE) INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iron sucrose is an intravenous iron replacement therapy that provides bioavailable iron in a sucrose-stabilized form. The iron is absorbed and incorporated into hemoglobin and iron storage proteins (ferritin) to correct iron deficiency. This formulation is designed for patients who cannot tolerate or absorb oral iron, particularly those with chronic kidney disease on hemodialysis.","oneSentence":"Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and treat iron deficiency anemia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:15.181Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia in patients with chronic kidney disease on hemodialysis"},{"name":"Iron deficiency anemia in patients with chronic kidney disease not on dialysis"},{"name":"Iron deficiency anemia in patients receiving erythropoiesis-stimulating agents"}]},"trialDetails":[{"nctId":"NCT05385042","phase":"NA","title":"Iron and Immune Response to Vaccine (IRONMUM)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2022-06-18","conditions":"Pregnancy Related","enrollment":171},{"nctId":"NCT07115121","phase":"NA","title":"Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-02-02","conditions":"Anemia","enrollment":40},{"nctId":"NCT06994065","phase":"NA","title":"Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients","status":"RECRUITING","sponsor":"Sindh Institute of Urology and Transplantation","startDate":"2025-06-02","conditions":"Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease","enrollment":128},{"nctId":"NCT06970925","phase":"EARLY_PHASE1","title":"Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery","status":"RECRUITING","sponsor":"Englewood Hospital and Medical Center","startDate":"2025-06-30","conditions":"Cardiac Surgery","enrollment":40},{"nctId":"NCT00239616","phase":"PHASE2","title":"Pharmacokinetic of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2002-06-05","conditions":"Anemia","enrollment":10},{"nctId":"NCT05251493","phase":"PHASE3","title":"Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy","status":"RECRUITING","sponsor":"Saskatchewan Health Authority - Regina Area","startDate":"2022-06-06","conditions":"Iron Deficiency Anaemia in Childbirth","enrollment":280},{"nctId":"NCT06968936","phase":"NA","title":"Perioperative Blood Conservation: Role of Combined Iron Supplementation Protocols in Reducing Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-15","conditions":"Anemia, Iron Deficiencies, Cardiac Surgery","enrollment":400},{"nctId":"NCT00236964","phase":"PHASE3","title":"Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2001-02-23","conditions":"Anemia","enrollment":96},{"nctId":"NCT06012760","phase":"NA","title":"The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-04","conditions":"Anemia, Iron Deficiency Anemia, Perioperative","enrollment":400},{"nctId":"NCT06911034","phase":"PHASE4","title":"Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women","status":"COMPLETED","sponsor":"CMH Multan Institute of Medical Sciences","startDate":"2024-02-01","conditions":"Iron Deficiency Anemia (IDA), Pregnancy","enrollment":60},{"nctId":"NCT06674486","phase":"PHASE1","title":"Bioequivalence Study of Iron Sucrose Injection in Healthy Participants","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2024-11-22","conditions":"Bioequivalency, Safety Issues","enrollment":48},{"nctId":"NCT05800600","phase":"PHASE2","title":"Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy","status":"RECRUITING","sponsor":"Fox Chase Cancer Center","startDate":"2023-03-15","conditions":"Anemia","enrollment":34},{"nctId":"NCT05353348","phase":"NA","title":"Effect of the Combined Programme on Perioperative Anaemia（CPPA）","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-15","conditions":"Patient Blood Management, Cardiac Surgery, Iron Deficiency Anemia","enrollment":110},{"nctId":"NCT06703411","phase":"PHASE4","title":"Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency","status":"COMPLETED","sponsor":"Cheng-Hsin General Hospital","startDate":"2023-05-01","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Hospitalization, Iron Deficiency","enrollment":76},{"nctId":"NCT06690450","phase":"PHASE4","title":"Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2001-08","conditions":"Hemodialysis","enrollment":400},{"nctId":"NCT00895232","phase":"PHASE2","title":"Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-11","conditions":"Restless Legs Syndrome","enrollment":21},{"nctId":"NCT06622148","phase":"PHASE1","title":"Bioequivalence Study of Iron Sucrose Injection in Healthy Subjects","status":"COMPLETED","sponsor":"Sichuan Huiyu Pharmaceutical Co., Ltd","startDate":"2024-06-25","conditions":"Bioequivalency, Safety Issues","enrollment":48},{"nctId":"NCT06596161","phase":"NA","title":"Iron Therpay and Fatigue in Women of Reprodcutive Age","status":"COMPLETED","sponsor":"Central Park Medical College","startDate":"2023-02-25","conditions":"Fatigue Syndrome, Chronic, Fatigue","enrollment":194},{"nctId":"NCT06556134","phase":"PHASE4","title":"Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Hassan II - Fès","startDate":"2021-07-01","conditions":"Anemia of Chronic Kidney Disease","enrollment":27},{"nctId":"NCT03893045","phase":"PHASE3","title":"A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects","status":"RECRUITING","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2019-09-18","conditions":"Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT03619850","phase":"PHASE3","title":"A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2018-08-13","conditions":"Chronic Kidney Disease; Iron Deficiency Anemia","enrollment":129},{"nctId":"NCT06487299","phase":"PHASE2","title":"Iron Administration Via Colonic TET Combined With WMT for ID","status":"NOT_YET_RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2024-07-25","conditions":"Iron Deficiency Anemia in Childbirth","enrollment":60},{"nctId":"NCT06366698","phase":"PHASE3","title":"Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia","status":"RECRUITING","sponsor":"Arrowhead Regional Medical Center","startDate":"2023-11-21","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":900},{"nctId":"NCT06248749","phase":"PHASE3","title":"Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"University of Saskatchewan","startDate":"2024-02-29","conditions":"Anaemia in Ovarian Carcinoma","enrollment":200},{"nctId":"NCT06061393","phase":"PHASE4","title":"Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia","status":"UNKNOWN","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2023-10-30","conditions":"Anemia, Iron Deficiency, Pregnancy Anemia","enrollment":200},{"nctId":"NCT01052779","phase":"PHASE2","title":"A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-03-01","conditions":"Iron Deficiency, Anemia, Kidney Disease","enrollment":162},{"nctId":"NCT05921968","phase":"PHASE4","title":"Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-07-30","conditions":"Iron Deficiency Anemia","enrollment":100},{"nctId":"NCT04855266","phase":"PHASE2","title":"Iron Sucrose in Patients With Iron Deficiency and POTS","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2021-04","conditions":"Iron-deficiency, Postural Orthostatic Tachycardia Syndrome","enrollment":""},{"nctId":"NCT05734716","phase":"PHASE4","title":"Colorado-Oregon Altitude Study","status":"COMPLETED","sponsor":"University of Oregon","startDate":"2021-02-17","conditions":"Acute Mountain Sickness","enrollment":121},{"nctId":"NCT05691257","phase":"PHASE4","title":"Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2023-02-01","conditions":"Heart Failure, Chronic Kidney Diseases, Anemia","enrollment":300},{"nctId":"NCT03933813","phase":"PHASE1, PHASE2","title":"Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2019-07-29","conditions":"Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia","enrollment":9},{"nctId":"NCT02441439","phase":"NA","title":"To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy","status":"WITHDRAWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2022-01-01","conditions":"Pregnancy","enrollment":""},{"nctId":"NCT04141631","phase":"NA","title":"Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-01-13","conditions":"Cardiac Surgery, Transfusion, Perioperative Anemia","enrollment":128},{"nctId":"NCT05581420","phase":"NA","title":"Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2022-06-02","conditions":"Inflammatory Bowel Diseases","enrollment":152},{"nctId":"NCT05489952","phase":"PHASE4","title":"Iron Supplementation for Geriatric Hip Fractures","status":"UNKNOWN","sponsor":"He Qifei","startDate":"2022-09-15","conditions":"Hip Fractures, Fragility Fracture, Osteoporotic Fractures","enrollment":444},{"nctId":"NCT01114204","phase":"PHASE3","title":"A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2010-08-10","conditions":"Iron Deficiency Anemia","enrollment":605},{"nctId":"NCT01227616","phase":"PHASE4","title":"Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis","status":"COMPLETED","sponsor":"AMAG Pharmaceuticals, Inc.","startDate":"2013-08","conditions":"Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD)","enrollment":296},{"nctId":"NCT04291690","phase":"NA","title":"The TARGET-EFT Randomized Clinical Trial","status":"COMPLETED","sponsor":"Jonathan Afilalo","startDate":"2020-03-05","conditions":"Frailty, Cardiovascular Diseases in Old Age, Geriatric Cardiology","enrollment":144},{"nctId":"NCT05151679","phase":"","title":"Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy","status":"AVAILABLE","sponsor":"Assiut University","startDate":"","conditions":"Iron Deficiency Anemia of Pregnancy","enrollment":""},{"nctId":"NCT00239642","phase":"PHASE4","title":"Safety and Efficacy of Iron Sucrose in Children","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2005-07","conditions":"Anemia, Chronic Kidney Disease","enrollment":141},{"nctId":"NCT03610230","phase":"NA","title":"Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients","status":"TERMINATED","sponsor":"The University of Hong Kong","startDate":"2019-02-01","conditions":"Iron Deficiency Anemia Treatment","enrollment":16},{"nctId":"NCT03516500","phase":"NA","title":"Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2018-05-09","conditions":"Lung Neoplasm, Segmentectomy;Intersegmental Plane","enrollment":20},{"nctId":"NCT03528564","phase":"PHASE2","title":"Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia","status":"TERMINATED","sponsor":"Unity Health Toronto","startDate":"2019-07-01","conditions":"Anemia, Iron Deficiency, Anemia of Chronic Disease, Hip Arthropathy","enrollment":4},{"nctId":"NCT03591406","phase":"PHASE3","title":"To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia","status":"COMPLETED","sponsor":"Vifor (International) Inc.","startDate":"2017-07-03","conditions":"Iron Deficiency Anemia","enrollment":371},{"nctId":"NCT00236938","phase":"PHASE3","title":"Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2002-07","conditions":"Anemia","enrollment":121},{"nctId":"NCT02707757","phase":"PHASE4","title":"Treatment Response in Dialysis Anaemia","status":"COMPLETED","sponsor":"Imperial College Healthcare NHS Trust","startDate":"2015-07","conditions":"Anaemia, Haemodialysis","enrollment":197},{"nctId":"NCT02458625","phase":"NA","title":"A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2016-04","conditions":"Postpartum Anemia","enrollment":158},{"nctId":"NCT00236977","phase":"PHASE3","title":"Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-08","conditions":"Anemia","enrollment":182},{"nctId":"NCT02940886","phase":"PHASE3","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2016-11-08","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia","enrollment":1512},{"nctId":"NCT02940860","phase":"PHASE3","title":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2016-11-29","conditions":"Iron Deficiency Anaemia, Iron Deficiency Anemia, Chronic Kidney Disease","enrollment":1538},{"nctId":"NCT02198495","phase":"PHASE4","title":"Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2014-09","conditions":"Anemia of Chronic Kidney Disease","enrollment":143},{"nctId":"NCT04464850","phase":"PHASE3","title":"Intravenous Versus Oral Iron Therapy in Hemodialysis Patients","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2020-07-29","conditions":"Hemodialysis Complication, Anemia, Iron Deficiency Anemia","enrollment":124},{"nctId":"NCT04155814","phase":"PHASE1","title":"Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2019-09-19","conditions":"Bioequivalance","enrollment":196},{"nctId":"NCT04491916","phase":"NA","title":"Iron Therapy in Patients With End-Stage Renal Disease","status":"UNKNOWN","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2020-04-01","conditions":"End-stage Renal Disease, Anemia, Cardiovascular Risk Factor","enrollment":200},{"nctId":"NCT03630029","phase":"PHASE1","title":"RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD","status":"WITHDRAWN","sponsor":"Renibus Therapeutics, Inc.","startDate":"2018-09-15","conditions":"Acute Kidney Injury","enrollment":""},{"nctId":"NCT04359368","phase":"","title":"Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2019-09-01","conditions":"Iron-deficiency, Hypersensitivity Reactions","enrollment":42},{"nctId":"NCT03508466","phase":"","title":"Mechanism of Hypersensitivity Reactions to Iron Nanomedicines","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-10-01","conditions":"Iron-deficiency","enrollment":42},{"nctId":"NCT02060851","phase":"PHASE4","title":"Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants","status":"COMPLETED","sponsor":"Kunshan First People's Hospital Affiliated to Jiangsu University","startDate":"2014-02","conditions":"Malnutrition","enrollment":96},{"nctId":"NCT04225728","phase":"PHASE4","title":"Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study","status":"COMPLETED","sponsor":"CN NGANOU-GNINDJIO, MD, MSc","startDate":"2017-12-01","conditions":"Chronic Heart Failure (CHF), Iron Deficiency","enrollment":45},{"nctId":"NCT03214627","phase":"NA","title":"Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial","status":"TERMINATED","sponsor":"Vifor Fresenius Medical Care Renal Pharma","startDate":"2018-12-10","conditions":"Anemia, End Stage Renal Disease","enrollment":88},{"nctId":"NCT02941081","phase":"PHASE2","title":"A Novel Nano-iron Supplement to Safely Combat Iron Deficiency and Anaemia in Young Children: a Doubleblind Randomised Controlled Trial","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2018-01-08","conditions":"Iron Deficiency, Anaemia in Children","enrollment":645},{"nctId":"NCT04016922","phase":"","title":"The Effect of Maternal Iron Deficiency Anemia on Fetal Hemodynamic and Neonatal Outcome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-07","conditions":"Fetal Conditions","enrollment":500},{"nctId":"NCT03658876","phase":"PHASE4","title":"Predictors of Response to Iron and Erythropoietin Stimulating Agents","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-06-03","conditions":"Renal Failure Chronic, Anemia","enrollment":197},{"nctId":"NCT02492672","phase":"","title":"Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2014-09","conditions":"Chronic Kidney Disease","enrollment":50},{"nctId":"NCT03917394","phase":"","title":"Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2019-04-24","conditions":"Anemia, Iron Deficiency","enrollment":780},{"nctId":"NCT02047552","phase":"PHASE2","title":"RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone","status":"WITHDRAWN","sponsor":"Denver Health and Hospital Authority","startDate":"2015-01","conditions":"Functional Iron Deficiency, Trauma, Anemia","enrollment":""},{"nctId":"NCT02610920","phase":"EARLY_PHASE1","title":"Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2015-12","conditions":"Breast Neoplasm, Carcinoma, Ductal, Breast, Carcinoma, Intraductal, Noninfiltrating","enrollment":""},{"nctId":"NCT03883841","phase":"","title":"Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-05","conditions":"Iron Deficiency Anemia","enrollment":60},{"nctId":"NCT03106298","phase":"","title":"Iron Deficiency and FGF23 Regulation in CKD and HF","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2015-12-18","conditions":"Chronic Kidney Diseases, Chronic Heart Failure, Iron Deficiency Anemia","enrollment":77},{"nctId":"NCT02130063","phase":"PHASE3","title":"IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose","status":"COMPLETED","sponsor":"Pharmacosmos A/S","startDate":"2014-05","conditions":"Iron Deficiency Anaemia","enrollment":511},{"nctId":"NCT02390102","phase":"PHASE3","title":"Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement","status":"COMPLETED","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2012-06","conditions":"Anemia, Aortic Stenosis","enrollment":117},{"nctId":"NCT03093883","phase":"PHASE1","title":"Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Azad Pharma AG","startDate":"2017-03-13","conditions":"Heathy Volunteers","enrollment":48},{"nctId":"NCT03009578","phase":"PHASE3","title":"Iron Sucrose Versus Ferrous Bis-glycinate for Treatment of Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-02-01","conditions":"Anemia","enrollment":100},{"nctId":"NCT02743572","phase":"NA","title":"Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants","status":"COMPLETED","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2015-09","conditions":"Premature Birth","enrollment":129},{"nctId":"NCT02731534","phase":"PHASE3","title":"Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia","status":"COMPLETED","sponsor":"Zeria Pharmaceutical","startDate":"2016-05","conditions":"Iron Deficiency Anemia","enrollment":238},{"nctId":"NCT00236951","phase":"PHASE3","title":"Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2003-02","conditions":"Anemia","enrollment":224},{"nctId":"NCT00721188","phase":"PHASE2","title":"Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2006-01","conditions":"Anemia","enrollment":11},{"nctId":"NCT00704353","phase":"PHASE3","title":"Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2008-06","conditions":"Anemia","enrollment":735},{"nctId":"NCT00981045","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2009-08","conditions":"Iron Deficiency Anemia, Impaired Renal Function","enrollment":2561},{"nctId":"NCT01290315","phase":"PHASE2","title":"Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2009-08","conditions":"Iron Deficiency Anemia","enrollment":49},{"nctId":"NCT01180894","phase":"NA","title":"IV Iron for the Anemia of Traumatic Critical Illness","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2011-06","conditions":"Trauma, ICU Anemia","enrollment":150},{"nctId":"NCT01151592","phase":"PHASE4","title":"Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)","status":"WITHDRAWN","sponsor":"American Regent, Inc.","startDate":"","conditions":"Iron Deficiency Anemia","enrollment":""},{"nctId":"NCT01984554","phase":"","title":"Observational Study on the Use of IV (Intravenous) Iron Therapy Among Subjects With Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2013-09","conditions":"Iron Deficiency Anemia (IDA)","enrollment":551},{"nctId":"NCT02009943","phase":"PHASE1","title":"Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill","status":"WITHDRAWN","sponsor":"Denver Health and Hospital Authority","startDate":"2017-02","conditions":"ICU Anemia, Functional Iron Deficiency","enrollment":""},{"nctId":"NCT00384657","phase":"PHASE3","title":"Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease","status":"WITHDRAWN","sponsor":"Anemia Working Group Romania","startDate":"2008-01","conditions":"Chronic Kidney Disease, Chronic Heart Failure, Anemia","enrollment":""},{"nctId":"NCT01978535","phase":"PHASE1, PHASE2","title":"Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2014-12-17","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":3},{"nctId":"NCT03317210","phase":"PHASE4","title":"Intravenous Treatment of Anemia in Pregnancy","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2002-09-01","conditions":"Anemia","enrollment":50},{"nctId":"NCT02977611","phase":"PHASE2","title":"The Safety of a High-Dose, Rapid Infusion of Iron Sucrose","status":"WITHDRAWN","sponsor":"The Guthrie Clinic","startDate":"2017-01","conditions":"Iron Deficiency","enrollment":""},{"nctId":"NCT02787824","phase":"PHASE4","title":"Periodic Versus Continuous IV Iron Supplementation in HD Patients","status":"COMPLETED","sponsor":"Papageorgiou General Hospital","startDate":"2016-05","conditions":"Anemia of Chronic Kidney Disease","enrollment":27},{"nctId":"NCT03157050","phase":"","title":"Intravenous Iron May Increase Depression Among Hemodialysis Patients","status":"COMPLETED","sponsor":"Benha University","startDate":"2016-01-14","conditions":"Depression, Hemodialysis Complication, Iron Deficiency Anemia","enrollment":112},{"nctId":"NCT00960921","phase":"PHASE2","title":"Study of the Effects of Iron on Lung Blood Pressure at High Altitude","status":"WITHDRAWN","sponsor":"University of Oxford","startDate":"","conditions":"Hypertension, Pulmonary","enrollment":""},{"nctId":"NCT02390921","phase":"PHASE4","title":"The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron","status":"COMPLETED","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2015-02","conditions":"Liposomated Iron, Y-de-Roux Gastric By-Pass, Parenteral Iron Therapy","enrollment":40},{"nctId":"NCT00719459","phase":"PHASE1","title":"Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer","status":"COMPLETED","sponsor":"Hospira, now a wholly owned subsidiary of Pfizer","startDate":"2008-06","conditions":"Healthy Volunteers","enrollment":60},{"nctId":"NCT01435200","phase":"PHASE3","title":"Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2011-06","conditions":"Gynecologic Cancer","enrollment":64},{"nctId":"NCT01857011","phase":"PHASE3","title":"Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2014-04","conditions":"Anemia, Iron-Deficiency, Weight Loss","enrollment":56},{"nctId":"NCT00830037","phase":"PHASE4","title":"A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease","status":"TERMINATED","sponsor":"Indiana University","startDate":"2008-08","conditions":"Chronic Kidney Disease, Iron-deficiency Anemia","enrollment":136},{"nctId":"NCT00318812","phase":"PHASE2, PHASE3","title":"Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-05","conditions":"Anemia, Renal Failure","enrollment":55},{"nctId":"NCT02762422","phase":"NA","title":"Serial Phlebotomy in Voluntary Blood Donors","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2009-06","conditions":"Atherosclerosis","enrollment":84},{"nctId":"NCT00660933","phase":"PHASE4","title":"Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2005-09","conditions":"Anemia, Puerperal Disorders","enrollment":70},{"nctId":"NCT01309659","phase":"PHASE2","title":"Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia","status":"TERMINATED","sponsor":"Duke University","startDate":"2011-05","conditions":"Anemia, Unexplained Anemia (UAE)","enrollment":19}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"DIARRHOEA"},{"count":1,"reaction":"HYPONATRAEMIA"},{"count":1,"reaction":"HYPOVOLAEMIC SHOCK"},{"count":1,"reaction":"MENTAL STATUS CHANGES"},{"count":1,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Venofer"],"phase":"marketed","status":"active","brandName":"Iron Sucrose (Venofer)","genericName":"Iron Sucrose (Venofer)","companyName":"American Regent, Inc.","companyId":"american-regent-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iron sucrose delivers iron directly into the bloodstream as a stable complex to replenish iron stores and treat iron deficiency anemia. Used for Iron deficiency anemia in patients with chronic kidney disease on hemodialysis, Iron deficiency anemia in patients with chronic kidney disease not on dialysis, Iron deficiency anemia in patients receiving erythropoiesis-stimulating agents.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}